prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, 1. M. Specimen # : Race: WHITE. Locatio. SPECIMEN: A: LEFT BREAST LUMPECTOMY B: SENTINEL LYMPH NODE #1. C: SENTINEL LYMPH NODE #2 D: SENTINEL LYMPH NODE #3. E: NON-SENTINEL NODE TISSUE. FINAL DIAGNOSIS: A. BREAST, LEFT, LUMPECTOMY: - TUMOR TYPE: INFILTRATING DUCTAL CARCINOMA. - NOTTINGHAM GRADE: 2 OF 3 (MODERATELY DIFFERENTIATED). - NOTTINGHAM SCORE: 7 OF 9. (Tubules=3 , Nuclei= 2, Mitoses= 2; mitotic count 8 per 10 HPF at. 40x power). - TUMOR SIZE (GREATEST DIMENSION) : 1.3 CM (MEASURED GROSSLY). - TUMOR NECROSIS: ABSENT. - MICROCALCIFICATIONS: ABSENT. - VENOUS / LYMPHATIC INVASION: ABSENT. - MARGINS : -DISTANCE OF TUMOR FROM NEAREST MARGIN IS 0.2 CM, FROM ANTERIOR. MARGIN (MEASURED GROSSLY). - INTRADUCTAL COMPONENT: DUCTAL CARCINOMA IN SITU, INTERMEDIATE. NUCLEAR GRADE (G2) WITH CENTRAL NECROSIS. ESTROGEN RECEPTORS POSITIVE (NEARLY 100% NUCLEAR STAINING, FROM. PREVIOUS BIOPSY. PROGESTERONE RECEPTORS: POSITIVE (95% NUCLEAR STAINING, FROM. PREVIOUS BIOPSY. - HER 2 NEU by IHC: NEGATIVE (1+, FROM PREVIOUS BIOPSY. - LYMPH NODES: SEE PARTS B, C, D, AND E. - PATHOLOGIC STAGE: pT1c NO (i-) MX. - ADDITIONAL PATHOLOGIC CHANGES : - FIBROCYSTIC CHANGES, INCLUDING CYSTS AND FIBROSIS. - CHANGES OF PRIOR BIOPSY. B. LYMPH NODE, SENTINEL #1, RESECTION: - ONE LYMPH NODE NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. C. LYMPH NODE, SENTINEL #2, RESECTION: - ONE LYMPH NODE NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. Specimen #: FINAL DIAGNOSIS (continued) : AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. D. LYMPH NODE, SENTINEL #3, RESECTION: - TWO LYMPH NODES NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN AND IMMUNOHISTOCHEMICAL CYTOKERATIN STAIN. E. SOFT TISSUE, NON-SENTINEL NODE TISSUE, RESECTION: - TWO LYMPH NODES NEGATIVE FOR MALIGNANCY BY HEMATOXYLIN. AND EOSIN STAIN. COMMENT: Part A: Immunohistochemical stains for e-cadherin (positive in. invasive carcinoma) cytokeratin 903 (positive in invasive carcinoma), ,. and. p63 (positive in myoepithelial cells), are reviewed with appropriate. controls. Parts B-D: Immunohistochemical stains for cytokeratin are reviewed with. controls. This case received prospective quality control review. R. CLINICAL DIAGNOSIS AND HISTORY. female with lump above left nipple. MMG showing. speculaced mass at twelve o' clock position with overlying skin retraction. US guided biopsy confirmed intraductal carcinoma. PRE-OPERATIVE DIAGNOSIS: Left breast cancer. GROSS DESCRIPTION: A. Received fresh, labeled with the patient's name,. designated "LEFT BREAST LUMPECTOMY" is an ovoid portion of soft tissue. oriented with a short stitch superior, long stitch lateral. The specimen. measures 8.0 cm medial to lateral, 6.5 cm superior to inferior, and 3. 0 cm. anterior to posterior. Located on the anterior surface is a 4.5 x 2.0 cm. lightly pigmented, superficial skin ellipse. No scar is identified. The. specimen is inked as follows: superior = blue, inferior = green, medial. =. Specimen #: GROSS DESCRIPTION (continued) : red, lateral = yellow, anterior = orange, and posterior = black. Serial. sections reveal a fairly well defined, firm, gritty, pink-white mass. measuring 1.3 x 1.2 x 0.8 cm. The mass shows focal congestion with an. embedded clip on sectioning. The mass is located subadjacent to the skin. ellipse coming to within 0.2 cm of the anterior inked margin, and 0.4 cm. of the superior margin. The remainder of the specimen is composed of. lobulated, yellow-tan, adipose tissue admixed with a moderate amount of. fibrous tissue. No additional lesions are identified. Cassette Summary : A1: Mass with skin. A2: Adjacent normal with superior margin. A3: Mass with adjacent normal. A4-A5: - Superior and posterior margins. A6: Skin with anterior margin. A7: Medial margin. A8: Medial margin. A9: Lateral and inferior margin. A10: Lateral and anterior margin. A11: Inferior margin. Matched sections of A1 and A3 are submitted in. for CBCP protocol. B. Received fresh, labeled with the patient's name. designated "SENTINEL LYMPH NODE #1" is a 2.0 x 2.0 x 1.0 cm portion of. soft tissue. The specimen is bisected to reveal a predominantly fatty cut. surface with a partial thin, rim of pink-tan, lymphoid tissue. The. specimen is submitted in cassettes B1 and B2. C. Received fresh, labeled with the patient's name,. designated "SENTINEL LYMPH NODE #2" is a 2.5 x 2.5 x 1.0 cm portion UL. soft tissue. The specimen is bisected to reveal a predominantly fatty,. cut surface with minimal lymphoid tissue identified. The specimen is. entirely submitted in cassettes C1 and C2. D. Received fresh, labeled with the patient's name,. designated "SENTINEL LYMPH NODE #3' is a 1.5 x 1.0 x 0.5 cm portion or. soft tissue. The specimen is bisected to reveal a predominantly fatty,. cut surface with minimal lymphoid tissue identified. The specimen is. entirely submitted in cassette D1. E. Received in formalin, labeled with the patient's name,. Specimen #: GROSS DESCRIPTION (continued). designated 'NON-SENTINEL NODE TISSUE" are two portions of. yellow-brown, lobulated, soft tissue measuring 2.0 x 1.5 x 0.7 cm, and 1. 1. x 0.4 x 0.4 cm. Both fragments are bisected to reveal a predominantly,. fatty, cut surface admixed with lymphoid tissue. The larger fragment is. submitted in cassette E1. The smaller is submitted in cassette E2.

expanded version (tokens=2045) : 
 The breast pathology report shows that the patient had a lumpectomy procedure on their left breast. The final diagnosis shows that the tumor type is infiltrating ductal carcinoma, and that they have a Nottingham grade of 2 out of 3, with a score of 7 out of 9 (with tubules being 3, nuclei being 2, and mitoses being 2). The tumor size is measured grossly at 1.3 cm, and there is no tumor necrosis or microcalcifications to be found. Venous/lymphatic invasion is absent, and the margin shows that the tumor was 0.2 cm from the nearest margin from an anterior view.

The intraductal component is ductal carcinoma in situ, intermediate nuclear grade (G2) with central necrosis. The receptor status shows that estrogen receptors are positive (nearly 100% nuclear staining, from previous biopsy), as well as progesterone receptors being positive (95% nuclear staining, from previous biopsy). HER 2 neu by IHC is negative (1+, from previous biopsy). There is no mention of tumor infiltrating lymphocytes in the report.

Lymphovascular invasion and calcification are also absent. The pathological stage is pT1c NO (i-) MX. The report also mentions fibrocystic changes, including cysts and fibrosis, and changes of prior biopsy. Further examination of the report shows that lymph nodes were taken for analysis, with

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2210) : 
 Pathology report shows left breast lumpectomy with infiltrating ductal carcinoma, Nottingham grade 2 of 3, score 7 of 9 with no necrosis or microcalcifications. Tumor is estrogen and progesterone receptor-positive with no lymphatic invasion or calcification. Intraductal component demonstrates intermediate nuclear grade (G2) with central necrosis. HER 2 neu status negative by IHC. Pathological stage is pT1c NO (i-) MX with negative lymph nodes. Fibrocystic changes present in biopsy and resection specimens.

